// App-Quantinova.ai

BSH19‐PO‐162 : The detection and management of inhibitors in severe haemophilia patients — the experience of a large UK paediatric tertiary haemophilia centre

Researchers

Presenter

  • C. Horgan

Principal Investigators

  • S. Elmoamly

  • J. Patel

  • H. Rebbapragada

  • J. Motwani

Medical Centers

  • Department of Haematology, Birmingham Childrens Hospital, Birmingham, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

  • Blood/haematological Diseases

Disease

  • Hemophilia

  • Gastrointestinal bleeding

Biomarkers

  • Alpha-1-microglobulin/bikunin precursor

Drug/Treatment

  • Recombinant Factor VIII

  • NiaStase

  • Rituximab

  • ReFacto

  • FVIII

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved